Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating olaparib, cediranib maleate, and standard chemotherapy in extensive stage small cell lung carcinoma; study terminat…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) [Phase 1]
Phase 1 study evaluating pembrolizumab monotherapy and combination therapy in advanced solid tumors and lung cancer; completed with results …
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients [Phase 2]
Phase II, single-arm study of AZD1775 monotherapy in relapsed small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab in combination with 177Lu-DOTA0-Tyr3-Octreotate for extensive-stage small cell lung cancer has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) [Phase 3]
Phase 3 CASPIAN trial update evaluating durvalumab with or without tremelimumab in combination with platinum-based chemotherapy for untreate…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC. [Phase 3]
Phase 3 trial update evaluating SHR-1316 with chemoradiotherapy in small-cell lung cancer is ongoing; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) [Phase 3]
Phase 3 trial comparing rovalpituzumab tesirine to topotecan in advanced/metastatic small cell lung cancer with high DLL3 after frontline ch…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 trial update evaluating a combination chemotherapy regimen in extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial assessing combination chemotherapy with peripheral stem cell transplantation in small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations [Phase 2]
Phase 2 trial evaluating olaparib monotherapy in relapsed small cell lung cancer patients with HR pathway gene mutations beyond BRCA1/2, ATM…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2] [Phase 2]
Phase 2 trial evaluating AZD6738 in combination with Olaparib in relapsed small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung Cancer [Phase 2]
A single-arm Phase 2 trial evaluating anlotinib hydrochloride in combination with irinotecan or docetaxel for second-line treatment of relap…
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Immunotherapy as Second-line in Patient With Small Cell Lung Cancer [Phase 2]
Phase 2 trial assessing immunotherapy as second-line treatment in small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. [Phase 3]
Phase 3 trial exploring camrelizumab in combination with apatinib, etoposide, and cisplatin for small-cell lung cancer is ongoing with unkno…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating LP002 in combination with chemotherapy for extensive-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment [Phase 2]
Phase 2 trial evaluating different doses of irinotecan and cisplatin as first-line treatment for extensive-stage small cell lung cancer is i…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer [Phase 3]
A Phase 3 trial comparing simultaneous integrated boost to routine IMRT in limited-stage small-cell lung cancer is reported as ongoing with …
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating once-daily simultaneous modulated accelerated thoracic radiotherapy in limited small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients [Phase 2]
Phase 2 trial evaluating combined atezolizumab with carboplatin and etoposide as neoadjuvant therapy for limited-stage small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC [Phase 2]
Phase 2 trial evaluating camrelizumab with apatinib, carboplatin, and etoposide in extensive-stage small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating anlotinib plus etoposide and carboplatin as first-line therapy for extensive-stage small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) [Phase 3]
Phase 3 trial of pembrolizumab with etoposide and platinum in extensive-stage small cell lung cancer has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) [Phase 3]
Phase 3 trial of rovalpituzumab tesirine as maintenance therapy after first-line platinum-based chemotherapy in extensive-stage small cell l…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluating dinutuximab plus irinotecan versus irinotecan alone in relapsed or refractory small cell lung cancer has comple…